Skip to main content
. 2014 Apr 2;2014:353614. doi: 10.1155/2014/353614

Figure 5.

Figure 5

Treatment with the human CRP-specific ASO ISIS 353512 improves blood vessel patency following RCCA ligation in CRPtg mice (a) but not in wild-type mice (b). Blood vessel patency was calculated as described in the Materials and Methods. The asterisks indicate *P < 0.05 for unpaired t-tests.